Johnson & Johnson, founded in 1886 and headquartered in New Brunswick, New Jersey, is a multinational corporation focused on healthcare products, including pharmaceuticals, medical devices, and consumer health goods. The company’s extensive portfolio includes well-known brands such as Tylenol, Band-Aid, and Neutrogena, positioning it as a leader in both consumer and medical markets.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Johnson & Johnson has a longstanding presence in the bond market, having issued its first bonds in the early 1980s. Notably, in August 2020, the company issued $5 billion in bonds to support its efforts against the COVID-19 pandemic, reflecting its commitment to innovation and public health. Current yields on Johnson & Johnson bonds are competitive within the healthcare sector, often reflecting the company’s strong credit rating and financial stability. Additionally, the company offers various bond features, including callable options, which appeal to a broad range of institutional investors.